RRML - Determination of the phosphorylated neurofilament subunit NF-H (pNF-H) in cerebro-spinal fluid as biomarker in acute traumatic spinal cord injuries
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- April 2024 -
 
A comprehensive review of Prof... 24
Recomandarea comună EFLM-COLA... 13
Monocyte to high-density lipop... 10
Anti-thyroid peroxidase (TPO) ... 10
Understanding the key differen... 9
Understanding the pathogenesis... 7
Function of the S1P pathway in... 6
Predictive value of expression... 6
Comparison of two analytical m... 5
The importance of tumor marker... 4

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 22(3)/2014 DOI:10.2478/rrlm-2014-0029
XML
TXT

Determination of the phosphorylated neurofilament subunit NF-H (pNF-H) in cerebro-spinal fluid as biomarker in acute traumatic spinal cord injuries

Didona Ungureanu, Ștefan Mircea Iencean, Cristina Dimitriu, Andrei Ștefan Iencean, Alexandru Tascu


Abstract:

Study objective. The objective of this study was to measure the phosphorylated neurofilament subunit NF-H (pNF-H) in cerebro-spinal fluid of patients with spinal cord injury and to determine the correlation between the pNF-H levels and the severity of the injury. Materials and methods. The study included 15 subjects with acute traumatic spinal cord injury: eight patients with complete spinal cord injury (SCI) and seven patients with incomplete SCI. All patients were classified according to the American Spinal Injury Association impairment scale (ASIA) and all patients underwent surgery during the first 24 hours (decompression, stabilization). We measured daily the heavy phosphorylated neurofilament subunit (pNF-H) concentration by sandwich ELISA test in CSF in all patients and we correlated the values of pNF-H with the clinical evolution. Results. For all patients with SCI pNF-H was detectable in CSF samples and the values were different in the cases of complete SCI toward the cases of incomplete SCI and the cerebro-spinal pNF-H level was more elevated in cases of complete SCI. The level of CSF pNF-H was ten to a hundred times higher in complete SCI than the level of CSF pNF-H in cases with incomplete SCI, where the level of this biomarker was close to normal. The patients with a favorable neurological evolution after treatment had a specific pattern of daily values of pNF-H: a sudden increase up to a maximum value then a progressive decrease until normal. The maximum values were different in each case, from 10 times up to 170 times higher than the normal. Conclusion. The phosphorylated form of the high-molecular-weight neurofilament subunit NF-H (pNF-H) in cerebro-spinal fluid can be a specific biomarker for spinal cord injury and it can distinguish the severity of SCI. pNF-H is a predictive biomarker because of its values pattern can show the reducing or stopping of the secondary lesion and the favorable result.

Keywords: biomarker, cerebro-spinal fluid, phosphorylated neurofilament subunit NF-H, spinal cord injury

Received: 9.1.2014
Accepted: 7.8.2014
Published: 7.9.2014

 
  PDF Download full text PDF
(498 KB)
     
 
How to cite
Ungureanu D, Iencean ȘM, Dimitriu C, Iencean AȘ, Tascu A. Determination of the phosphorylated neurofilament subunit NF-H (pNF-H) in cerebro-spinal fluid as biomarker in acute traumatic spinal cord injuries. Rev Romana Med Lab. 2014;22(3):377-86. DOI:10.2478/rrlm-2014-0029